This compound is primarily utilized in the synthesis of chiral intermediates for pharmaceuticals, particularly in the production of enantiomerically pure drugs. It serves as a key building block in the development of active pharmaceutical ingredients (APIs) that target neurological and cardiovascular disorders. Its chiral nature allows for the creation of more effective and specific medications with reduced side effects. Additionally, it is employed in research settings for studying stereoselective reactions and enzyme interactions, aiding in the design of novel therapeutic agents. Its benzyl ester group also makes it a useful protective group in peptide synthesis, ensuring selective reactions during complex molecular constructions.